相关实验视频

Updated: Jun 29, 2025

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

在小鼠模型 (C57bl/6小鼠) 中,拉帕米辛对肝纤维化的有益作用

Hyun Goo Kang¹, Heesun Park¹, Ga Eun Myong¹

¹Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, Republic of Korea.

Transplantation proceedings

|March 28, 2024

概括

拉帕米辛在小鼠中显示出对肝纤维化的保护作用. 它显著降低了肝损伤标志物和炎症性细胞因子,表明这种疾病的治疗潜力.

科学领域:

药理学药理学是指药理学的学科.
肝病学肝病学是一种肝病学.
免疫学免疫学免疫学

背景情况:

肝纤维化是一种进展性炎症性疾病,死亡率高.
慢性肝损伤需要对新型治疗药物的研究.
了解保护机制对于管理肝纤维化至关重要.

研究的目的:

在实验诱导的慢性肝损伤的小鼠模型中研究拉巴胺的保护作用.
为了评估拉巴胺对肝功能生物化学参数的影响.
评估拉巴素在肝纤维化中对炎症标志物的调节.

主要方法:

二十四只小鼠被随机分配到四个组:正常,肝纤维化 (LF),用拉帕米治疗的LF和用西利马林治疗的LF.
作为治疗干预措施,使用了口服拉帕米辛和西利马林.
分析了生物化学参数 (肝功能酶,尿素,肌素) 和炎症性细胞因子表达.

主要成果:

与LF组相比,口服拉帕米辛显著降低了阿斯巴酸氨基转移酶,氨基转移酶,尿素和肌素水平.
拉巴胺治疗导致了对互白素-10 (IL-10),互白素-1β (IL-1B),可诱导的氧化合成酶 (iNOS) 和瘤缩因子-α (TNF-α) 的显著减少.
这些发现表明,在拉帕米辛的使用后,肝脏损伤和炎症的减少.

结论:

拉巴胺在小鼠实验诱导的肝纤维化方面显示出显著的保护作用.
这项研究强调了拉帕米辛作为治疗肝纤维化的治疗剂的潜力.
需要进一步的研究来探索拉帕米在肝脏疾病中的临床适用性.

更多相关视频

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...